Physicochemical Properties
| Molecular Formula | C18H19IN2O2 |
| Molecular Weight | 422.260136842728 |
| Exact Mass | 422.049 |
| CAS # | 333357-56-5 |
| PubChem CID | 589919 |
| Appearance | White to off-white solid powder |
| LogP | 1.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Heavy Atom Count | 23 |
| Complexity | 371 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | C(NC1=CC=C(I)C=C1)(=O)C1=CC=C(CN2CCOCC2)C=C1 |
| InChi Key | ZOFBYPLMJZJZIK-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C18H19IN2O2/c19-16-5-7-17(8-6-16)20-18(22)15-3-1-14(2-4-15)13-21-9-11-23-12-10-21/h1-8H,9-13H2,(H,20,22) |
| Chemical Name | N-(4-iodophenyl)-4-(morpholin-4-ylmethyl)benzamide |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | Compound 1, HIF-1 Inhibitor-4, inhibits HIF-1 with an IC50 of 560 nM (measured using U251 cells that express the PLAP reporter gene under the VEGF promoter (VEGF-PLAP)). [1]. |
| References |
[1]. Synthesis and structure-activity relationships of novel, potent, orally active hypoxia-inducible factor-1 inhibitors. Bioorg Med Chem. 2014 Oct 1;22(19):5513-29. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~25 mg/mL (~59.21 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 1.11 mg/mL (2.63 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 11.1 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 1.11 mg/mL (2.63 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 11.1 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.3682 mL | 11.8410 mL | 23.6821 mL | |
| 5 mM | 0.4736 mL | 2.3682 mL | 4.7364 mL | |
| 10 mM | 0.2368 mL | 1.1841 mL | 2.3682 mL |